EUVIMEDEUVIMED entdecken
Crossref

Structure‐Metabolism Relationships of Benzimidazole Derivatives with anti‐ Trypanosoma cruzi Activity for Chagas Disease

Rocío Marisol Espinoza-Chávez iD, Celso de Oliveira Rezende Júnior iD, Mariana Laureano de Souza, Rafael Consolin Chelucci iD, Simone Michelan-Duarte iD, Renata Krogh iD, Leonardo Luiz Gomes Ferreira, Marilia Valli iD, Aldo Sena de Oliveira, Adriano D Andricopulo iD, Luiz Carlos Dias iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Rocío Marisol Espinoza-Chávez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Synthetic Organic Chemistry, Institute of Chemistry, State University of Campinas (Unicamp), Campinas-SP, 13084-971, Brazil. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Benzimidazoles, Trypanocidal Agents, Chagas Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study introduces further insights from the hit‐to‐lead optimization process involving a series of benzimidazole derivatives acting as inhibitors of the cruzain enzyme, which targets Trypanosoma cruzi , the causative parasite of Chagas disease. Here, we present the design, synthesis and biological evaluation of 30 new compounds as a third generation of benzimidazole analogues with trypanocidal activity, aiming to enhance our understanding of their pharmacokinetic profiles and establish a structure‐metabolism relationships within the series. The design of these new analogues was guided by the analysis of previous pharmacokinetic results, considering identified metabolic sites and biotransformation studies. This optimization resulted in the discovery of two compounds ( 42 e and 49 b ) exhibiting enhanced metabolic stability, anti‐ Trypanosoma cruzi activity compared to benznidazole (the reference drug for Chagas disease), as well as being non‐cruzain inhibitors, and demonstrating a satisfactory in vitro pharmacokinetic profile. These findings unveil a new subclass of aminobenzimidazole and rigid compounds, which offer potential for further exploration in the quest for discovering novel classes of antichagasic compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosoma cruziBenzimidazolesTrypanocidal AgentsChagas DiseaseStructure-Activity RelationshipMolecular StructureParasitic Sensitivity TestsHumansAnimalsDose-Response Relationship, Drug

Stichwörter der Autor:innen

BenzimidazolesChagas diseaseDrug designHit-to-lead explorationMetabolic stabilityTrypanosoma cruzi

Substanzen

BenzimidazolesTrypanocidal Agentsbenzimidazole

Autor:innen und Institutionen

  • Laboratory of Synthetic Organic Chemistry, Institute of Chemistry, State University of Campinas (Unicamp), Campinas-SP, 13084-971, Brazil.
  • Institute of Chemistry, Federal University of Uberlândia (UFU), Uberlândia-MG, 38400-902, Brazil.
  • Laboratory of Medicinal and Computational Chemistry, Physics Institute of Sao Carlos (IFSC), University of Sao Paulo (USP), Sao Carlos-SP, 13563-120, Brazil.
  • Department of Exact Sciences and Education, Federal University of Santa Catarina (UFSC), Blumenau-SC, 89036-004, Brazil.

ORCID-Profile: Rocío Marisol Espinoza-Chávez, Celso de Oliveira Rezende Júnior, Rafael Consolin Chelucci, Simone Michelan-Duarte, Renata Krogh, Marilia Valli, Adriano D Andricopulo, Luiz Carlos Dias

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
  • DINOBBIO

Zitieren

APA

Espinoza-Chávez, R. M., de Oliveira Rezende Júnior, C., Laureano de Souza, M., Consolin Chelucci, R., Michelan-Duarte, S., Krogh, R., Gomes Ferreira, L. L., Valli, M., Sena de Oliveira, A., Andricopulo, A. D., & Carlos Dias, L. (2024). Structure‐Metabolism Relationships of Benzimidazole Derivatives with anti‐ Trypanosoma cruzi Activity for Chagas Disease. ChemMedChem. https://doi.org/10.1002/cmdc.202400293

Vancouver

Espinoza-Chávez RM, de Oliveira Rezende Júnior C, Laureano de Souza M, Consolin Chelucci R, Michelan-Duarte S, Krogh R, et al. Structure‐Metabolism Relationships of Benzimidazole Derivatives with anti‐ Trypanosoma cruzi Activity for Chagas Disease. ChemMedChem. 2024. doi:10.1002/cmdc.202400293

BibTeX
@article{EspinozaChvez2024,
  author = {Espinoza-Chávez, Rocío Marisol and de Oliveira Rezende Júnior, Celso and Laureano de Souza, Mariana and Consolin Chelucci, Rafael and Michelan-Duarte, Simone and Krogh, Renata and Gomes Ferreira, Leonardo Luiz and Valli, Marilia and Sena de Oliveira, Aldo and Andricopulo, Adriano D and Carlos Dias, Luiz},
  title = {Structure‐Metabolism Relationships of Benzimidazole Derivatives with anti‐ Trypanosoma cruzi Activity for Chagas Disease},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400293}
}
Kostenlos starten →